Plus Therapeutics Highlights Presentation, Says 'Nine of 20 Patients With LM Primary Breast Cancer Were Treated and Evaluable Through Five Dose Escalation Cohorts, With the Maximum Tolerated Dose yet to Be Reached'
- Headlines
- Plus Therapeutics Highlights Presentation, Says 'Nine of 20 Patients With LM Primary Breast Cancer Were Treated and Evaluable Through Five Dose Escalation Cohorts, With the Maximum Tolerated Dose yet to Be Reached'
Plus Therapeutics Highlights Presentation, Says 'Nine of 20 Patients With LM Primary Breast Cancer Were Treated and Evaluable Through Five Dose Escalation Cohorts, With the Maximum Tolerated Dose yet to Be Reached'
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
01:27
"Cancellation-based repurchase" has become an important means for Brokerages in Market Cap management.
00:52
The release of Open Source Harmony 5.0 accelerates the industrialization of domestic operating software.
00:50
The central bank intensifies support for liquidity, ensuring a stable financial environment as the year ends.
China Everbright Bank-0.54%